Cargando…

Phosphodiesterase type 5 inhibitors after left ventricular assist device: no free lunch?

Detalles Bibliográficos
Autores principales:	Grandin, E. Wilson, Teuteberg, Jeffrey J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318508/ https://www.ncbi.nlm.nih.gov/pubmed/33969639 http://dx.doi.org/10.1002/ehf2.13393

Ejemplares similares

Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure
por: Papathanasiou, Maria, et al.
Publicado: (2023)

Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation
por: Jakstaite, Aiste‐Monika, et al.
Publicado: (2021)

Implantable hemodynamic monitoring and management of left ventricular assist devices: Optimal or optional?
por: Lampert, Brent C., et al.
Publicado: (2021)

Phosphodiesterase‐5 Inhibitor Therapy for Left Ventricular Assist Device Patients: More Data, More Questions
por: Gulati, Gaurav, et al.
Publicado: (2020)

Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation
por: Xanthopoulos, Andrew, et al.
Publicado: (2020)

Despise the free lunch
por: Almadi, Majid A, et al.
Publicado: (2021)

Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Management?
por: Mondaini, Nicola
Publicado: (2020)

Re‐Thinking Re‐Synching in Left Ventricular Assist Device Recipients
por: Vader, Justin M., et al.
Publicado: (2018)

Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
por: Islam, Bianca N., et al.
Publicado: (2018)

The changing landscape of left ventricular assist device care in the setting of a pandemic
por: Amadio, Jennifer M., et al.
Publicado: (2020)

Left Ventricular Assist Device Implantation and Kidney Function: Chicken, Egg, or Omelet?
por: Roehm, Bethany, et al.
Publicado: (2021)

The School Lunch
Publicado: (1914)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support
por: Critsinelis, Andre, et al.
Publicado: (2018)

Echocardiography in Left Ventricular Assist Device
por: Helmy, Sherif M., et al.
Publicado: (2010)

Ventricular Assist Devices: an Evolving Field
por: Kubrusly, Luiz Fernando
Publicado: (2019)

Effect of Phosphodiesterase Inhibitor on Diabetic Nephropathy
por: Kang, Shin-Wook
Publicado: (2012)

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Shehab, Sajad, et al.
Publicado: (2019)

Temporary Right Ventricular Assist Device Insertion via Left Thoracotomy after Left Ventricular Assist Device Implantation
por: Park, Ilkun, et al.
Publicado: (2019)

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers
por: Wang, Joseph I., et al.
Publicado: (2020)

Left ventricular assist device implantation in left ventricular aneurysm: The turtleneck technique
por: Haidari, Zaki, et al.
Publicado: (2022)

Changes in Left Ventricular Ejection Fraction and Oxidative Stress after Phosphodiesterase Type-5 Inhibitor Treatment in an Experimental Model of Retrograde Rat Perfusion
por: Krivokapic, Milos, et al.
Publicado: (2023)

The diagnosis of left ventricular assist device thrombosis
por: Gerds, H.Z.R., et al.
Publicado: (2015)

Perioperative management of left ventricular assist devices
por: Sanjay, O. P.
Publicado: (2016)

Hyperkalemia in Patients With Left Ventricular Assist Devices
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Left Ventricular Assist Devices and Renal Ramifications
por: Nair, Ajith, et al.
Publicado: (2023)

Association of pre–left ventricular assist device defibrillator shocks for ventricular arrhythmia with clinical outcomes after left ventricular assist device implantation
por: Wann, Daniel G., et al.
Publicado: (2023)

Ventricular Tachycardia Ablation in Patients with Left Ventricular Assist Devices
por: Patil, Kaustubha D., et al.
Publicado: (2019)

Left Ventricular Assist Device under Chronic Kidney Disease: Cautious, But We Still Need More Details
por: Lee, Soo Yong
Publicado: (2021)

Metabolic Reprogramming After Left Ventricular Assist Device: Remodeling Without Recovery of Cardiac Energetics
por: Rame, J. Eduardo, et al.
Publicado: (2016)

Peers bring back free lunch
Publicado: (2002)

Blow-up: a free lunch?
por: Koenderink, Jan, et al.
Publicado: (2012)

“No Such Thing as a Free Lunch”: Personalized P2Y(12) Inhibition to Optimize Patient Outcomes
por: Kinnaird, Tim
Publicado: (2019)

A case of left ventricular free wall rupture after insertion of an IMPELLA® left ventricular assist device diagnosed by transesophageal echocardiography
por: Mizuno, Akito, et al.
Publicado: (2021)

AB030. Evolution of phosphodiesterase type 5 inhibitors
por: Moon, Du Geon
Publicado: (2016)

COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device
por: Ajmal, Maryam, et al.
Publicado: (2022)

Loss of Left Ventricular Vortex Ring in Left Ventricular Assist Device-Induced Right Ventricular Failure
por: Akiyama, Koichi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8g6crrtes4nor18l6rqjm2vc14